Levitee Labs Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVT.CN research report →
Companywww.leviteelabs.com
Levitee Labs Inc. , a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products.
- CEO
- David Bentil
- IPO
- 2021
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $502.09K
- P/E
- -0.03
- P/S
- 0.29
- P/B
- 0.04
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 39.95%
- Op Margin
- -638.70%
- Net Margin
- -662.39%
- ROE
- -258.68%
- ROIC
- -105.71%
Growth & Income
- Revenue
- $1.72M · 0.00%
- Net Income
- $-11,402,682 · -2389.92%
- EPS
- $-0.19 · -3233.33%
- Op Income
- $-10,994,900
- FCF YoY
- -3766.25%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.28
- Avg Volume
- 0
Get TickerSpark's AI analysis on LVT.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LVT.CN Coverage
We haven't published any research on LVT.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LVT.CN Report →